April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Role of Phospholipase A2 (PLA2) Inhibitors in Prevention of Apotheosis of the Corneal Epithelial Cells and Mitigation of Acanthamoeba keratitis
Author Affiliations & Notes
  • Hassan Alizadeh
    Cell Biology and Anatomy,
    UNTHSC Fort Worth TX, Fort Worth, Texas
  • Haochuan Li
    Ophthalmology,, University of Texas Southwestern Medical Center, Dallas, Texas
  • Sudha Neelam
    Graduate School of Biomedical Sciences,
    UNTHSC Fort Worth TX, Fort Worth, Texas
  • Footnotes
    Commercial Relationships  Hassan Alizadeh, None; Haochuan Li, None; Sudha Neelam, None
  • Footnotes
    Support  NIH /NEI grant RO1-EY09756
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5795. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hassan Alizadeh, Haochuan Li, Sudha Neelam; Role of Phospholipase A2 (PLA2) Inhibitors in Prevention of Apotheosis of the Corneal Epithelial Cells and Mitigation of Acanthamoeba keratitis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5795.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have identified the mannose-induced protein (MIP-133) from A. castellanii trophozoites. MIP-133 plays an important role in the pathogenesis of infection and induced apoptosis of human and Chinese hamster corneal epithelial cells. The aim of this study is to determine if MIP-133 induces apoptosis of corneal epithelial cells through phospholipase A2 (PLA2) mediated pathways.The efficacy of PLA2 inhibitors to provide protection against Acanthamoeba keratitis was examine in vivo.

Methods: : Human corneal epithelial cells (HCE) were incubated in the presence or absence of MIP-133 for 24 hr and extracellular arachidonic acid release assay were performed. Percent apoptosis was determined by the caspase-3 assay. The effect of various PLA2 inhibitors on apoptosis and arachidonic acid release was tested in vitro. Inhibition experiments involved pre-incubating the corneal epithelial cells for 1 hr with either 10 uM of MAFP (Methyl-arachidonyl fluorophosphonate) or 20 uM AACOCF3 (Arachidonyl trifluoromethyl ketone) selective inhibitor of human cytosolic PLA2(cPLA 2). Animals were infected with A. castellanii-laden contact lenses. MAFP (50ug/5ul) was injected under the contact lens of an infected cornea three times a day for 7 days after infection. Control animals were treated with 5ul of PBS. Keratitis was observed 7 days after infection

Results: : MIP-133 induced significant arachidonic acid release from HCE cells and PLA2 inhibitors significantly reduced arachidonic acid release from HCE cells (P<0.05). MIP-133-induced apoptosis in corneal cells and PLA2 inhibitors significantly inhibited MIP-133-induced apoptosis in the HCE cells (P<0.05). Treatment with the PLA2 inhibitor had a profound effect on the severity and chronicity of keratitis. In addition, hamsters treated with PLA2 inhibitor had significantly less severe keratitis as compared with control groups.

Conclusions: : These results indicate that PLA2 is involved in apoptosis and arachidonic acid release from corneal epithelial cells that induced by MIP-133. Moreover, PLA2 inhibitors can be used as a therapeutic target in Acanthamoeba keratitis.

Keywords: Acanthamoeba • cornea: basic science • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×